ZURICH Oct 3The Swiss blue-chip SMI was
seen opening almost unchanged at 8,142 points on Monday,
according to premarket indications by bank Julius Baer
The following are some of the main factors expected to
affect Swiss stocks:
Novartis's psoriasis drug Cosentyx showed long-term efficacy
in keeping patients' skin clear, the Swiss drugmaker said on
Saturday, citing a study it hopes will ultimately help the
company to win business from rival medicines made by Amgen
and Johnson & Johnson.
Novartis also presented findings from global survey to date
of people with psoriasis, which showed many do not achieve the
treatment goal of clear skin or even believe it is a realistic
For more news, click on
China's HNA Group, which owns Swissport, Gategroup
and SR Technics, is looking for further buys in Switzerland, its
CEO told Finanz und Wirtschaft.
For more news, click on
* Roche said first phase III data on TECENTRIQ
(atezolizumab) will feature at the 2016 European Society for
Medical Oncology (ESMO) Congress.
* SGS announced the acquisition of Roos+Bijl,
headquartered in Rhoon, the Netherlands. The company is expected
to generate 2016 revenues in excess of 7 million euros, SGS
said. SGS also said it is investing in a new facility in Berlin
to expand its R&D/QC testing activities, and to offer new
analytical services to clients.
* Schindler Holding said it has completed the sale
of its operations in Japan to Otis Japan.
* Clariant said it will exhibit at CPhI Worldwide
2016 to show pharmaceutical professionals new ways to protect
products and ensure access to safe medicines for patients.
* Accu Holding reported a first half net loss of
21.1 million Swiss francs. The company's suspension from the
Swiss stock exchange was lifted after the publication of the
* Datwyler said it has completed the completion of
technology and materials company Ott.
* Temenos said "a major European bank" had selected
UniversalSuite, its front-to-back solution for retail,
commercial and corporate banking.
* Tecan said it had successfully completed the
acquisition of SPEware Corporation.
* HBM Healthcare Investments said it terminated its
share buy-back programme 2014
* Ascom said its divestment of the Network Testing
Division to InfoVista was successfully closed on Sept. 30. Ascom
said it was "now a one business company" focused on healthcare
ICT and mobile workflow solutions.
* Airopack posted a net loss of 16.2 million euros
for the first half of 2016.
* USI Group Holdings said it expects its merger
with RP&C International to occur this week, once all regulatory
approvals have been obtained.
* SE Swiss Estates said first-half net profit was
488,000 francs, compared to 367,000 francs in the previous year.
* Swiss retail sales data for August is due to be
released at 0715 GMT.
* Manufacturing Purchase Managers Index is due
to be released at 0730 GMT.
* The Swiss National Bank releases sight deposits data at
(Reporting by Zurich newsroom)